Toripalimab (Anti-PDCD1 / PD-1 / CD279)
Toripalimab (Anti-PDCD1 / PD-1 / CD279) is a recombinant, humanized monoclonal antibody targeting PD-1. It has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma. 147.3 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3082 |
| Sku # | A3082-1mg*5 |
| Pricing | 1mg*5, $490.00 |